All News #Library
Biotech
AvenCell Doses First Patient in Phase I QUADvance AVC-203 Study
02 Apr 2026 //
PR NEWSWIRE
ViroCell & AvenCell Collaborate on CAR-T for Blood Cancers
29 Jul 2025 //
BUSINESSWIRE
AvenCell bags $112M to flick `switchable` CAR-Ts in the clinic
22 Oct 2024 //
FIERCE BIOTECH

Market Place
Sourcing Support